Maria do Carme Pampín Casal
Chief Executive Officer at GalChimia SA
Profile
Maria do Carme Pampín Casal is the founder and the Chief Executive Officer of GalChimia SA, a company founded in 2001.
She is also the founder and Director of Origo Biopharma SL, a company founded in 2017.
Dr. Pampín Casal holds a doctorate degree from the University of Santiago de Compostela.
Maria do Carme Pampín Casal active positions
| Companies | Position | Start |
|---|---|---|
GalChimia SA
 GalChimia SA Chemicals: SpecialtyProcess Industries GalChimia SA engages in the manufacture and commercialization of chemical products including pharmaceutical substances, chemical reagents, pesticide additives and synthetic industrial acids. The firm also offers custom synthesis, contract research, process development and reaction optimization services. The company was founded by Carme Pampin, Gabriel Tojo, Pampin Casal Maria Do Carme and Jacobo Cruces in 2001 and is headquartered in A Coruna, Spain. | Chief Executive Officer | 2000-12-31 |
Origo Biopharma SL
 Origo Biopharma SL BiotechnologyHealth Technology Part of AgomAb Therapeutics NV, Origo Biopharma SL engages in research and development of immunotherapeutic products which are focused on treating health disorders. The company is based in A Coruña, Spain. The Spanish company was founded in 2017 by Maria do Carme Pampín Casal, Julio Castro-Palomino Laria. The CEO is Ramon Bosser. Origo Biopharma was acquired by AgomAb Therapeutics NV on December 15, 2021. | Founder | 2016-12-31 |
Training of Maria do Carme Pampín Casal
| University of Santiago de Compostela | Doctorate Degree |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
GalChimia SA
GalChimia SA Chemicals: SpecialtyProcess Industries GalChimia SA engages in the manufacture and commercialization of chemical products including pharmaceutical substances, chemical reagents, pesticide additives and synthetic industrial acids. The firm also offers custom synthesis, contract research, process development and reaction optimization services. The company was founded by Carme Pampin, Gabriel Tojo, Pampin Casal Maria Do Carme and Jacobo Cruces in 2001 and is headquartered in A Coruna, Spain. | Process Industries |
Origo Biopharma SL
Origo Biopharma SL BiotechnologyHealth Technology Part of AgomAb Therapeutics NV, Origo Biopharma SL engages in research and development of immunotherapeutic products which are focused on treating health disorders. The company is based in A Coruña, Spain. The Spanish company was founded in 2017 by Maria do Carme Pampín Casal, Julio Castro-Palomino Laria. The CEO is Ramon Bosser. Origo Biopharma was acquired by AgomAb Therapeutics NV on December 15, 2021. | Health Technology |
- Stock Market
- Insiders
- Maria do Carme Pampín Casal
